Ozempic

Royal treatment, neurodiverse history & is everyone on Ozempic?

45 min listen

First: a look ahead to President Trump’s state visit next week Transatlantic tensions are growing as the row over Peter Mandelson’s role provides an ominous overture to Donald Trump’s state visit next week. Political editor Tim Shipman has the inside scoop on how No. 10 is preparing. Keir Starmer’s aides are braced for turbulence. ‘The one thing about Trump which is entirely predictable is his unpredictability,’ one ventures. And government figures fear he may go off message on broadcast – he is scheduled to be interviewed by GB News. It is rare for leaders to receive a second visit, especially those in their second term. But, as Tim says, ‘Britishness is

A Spartan’s guide to body shaming

Now that new drugs have allowed the government’s Fat Controller to celebrate a nation of skinnies – let us hope the drugs are not too temptingly tasty – he will not have to adopt the Spartan custom of checking their naked young men every ten days for signs of excessive thinness or corpulence. In Greek eyes, obesity was particularly associated with luxury. On their tomb paintings, Etruscans tended to depict aristocrats at dinner as very fat and even more contented. Ptolemy Alexander, a Greek king of Egypt, needed two people to support him when he left the room to relieve himself. The vast Dionysius, tyrant of Heraclea (coast of north

Could Ozempic cure your phone addiction?

It’s already known for whittling down waistlines – and now Ozempic looks set to have the same effect on wine consumption. Research recently published in the journal JAMA Psychiatry found semaglutide, the weight loss medication also sold under the brand name Wegovy, reduced cravings in people with alcohol use disorder.  The study by California’s USC Institute for Addiction Science divided 48 participants into two groups and found those injected with semaglutide drank less in each sitting than those offered a placebo. It is not the first research to link the jabs – originally designed as a diabetes treatment – to lower incidence of substance abuse. In October it was suggested in

Could Ozempic bankrupt the NHS?

The NHS spends around £6.5 billion every year treating obesity. People who are overweight cost the health service twice as much as those who maintain a healthy weight. Half of all cancer cases are linked to obesity and being severely overweight significantly increases the risk of other conditions, such as diabetes, strokes and heart attacks. No public health campaign or intervention has ever worked. Obesity rates have nearly doubled in the UK since the 1990s. More than 60 per cent of adults are overweight. It’s hoped that weight-loss injections, known as GLP-1 agonists – semaglutide (also known as Wegovy or Ozempic) and the more recent market entry tirzepatide (Mounjaro) –

Jeremy Hunt should stick to sensible pledges – it’s too late for big moves

Imagine you’re Chancellor Jeremy Hunt, drafting your Autumn Statement for delivery in three weeks’ time. Bookies’ odds for a Tory general election win have moved out to six-to-one (against Labour’s dead-cert one-to-seven) following by-election wipe-outs. The Lib Dems look set to nab your South West Surrey seat if you don’t stand down anyway. And you can’t give your back-benches red-meat tax cuts because public borrowing for this year could run £30 billion higher than forecast. Releasing the pension ‘triple lock’ to save money would alienate older Tories. Inheritance tax giveaways that might please them would be campaign gold for Labour. A stamp duty cut would do nothing for floating-vote home-buyers facing